Results 191 to 200 of about 100,641 (375)

Application of Mathematical Models in Drug Release Kinetics of Carbidopa and Levodopa ER Tablets

, 2017
H. Baishya
semanticscholar   +1 more source

Levodopa and the progression of Parkinson's disease.

New England Journal of Medicine, 2004
S. Fahn, D. Oakes, I. Shoulson, K. Kieburtz, A. Rudolph, A. Lang, C. Olanow, C. Tanner, K. Marek   +8 more
semanticscholar   +1 more source

Levodopa Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: DUOGLOBE Final 3-Year Results

, 2023
К. Ray Chaudhuri, Norbert Kovács, Francesco E. Pontieri, Jason Aldred, Paul Bourgeois, Thomas L. Davis, Esther Cubo, Marieta Anca‐Herschkovitsch, Robert Iansek, Mustafa Siddiqui, Mihaela Simu, Lars Bergmann, M. Ballina, Pavnit Kukreja, Omar Ladhani, Jia Jia, David G. Standaert   +16 more
openalex   +2 more sources

Computer Vision Analysis for Objective Motor Assessment in Parkinson's Disease: A Retrospective Study

Movement Disorders Clinical Practice, EarlyView.
Abstract Background The Movement Disorder Society‐Unified Parkinson's Disease Rating Scale‐Part III (MDS‐UPDRS‐III) is subjective and insensitive to subtle changes in patients with Parkinson's disease (PD). Computer vision (CV) can extract objective kinematics from routine outpatient videos, potentially augmenting the accuracy of the motor assessment ...
Pasquale Maria Pecoraro, Luca Marsili, Antonio Cannavacciuolo, Kevin R. Duque, Jesus Abanto, Jennifer Sharma, Jennifer Scheler, Heba A. Deraz, Lauren Wingler, Vincenzo Di Lazzaro, Alberto J. Espay, Lazzaro di Biase, Matteo Bologna   +12 more
wiley   +1 more source

The catechol-O-methyltransferase and monoamine oxidase B polymorphisms and levodopa therapy in the Iranian patients with sporadic Parkinson’s disease

, 2012
Anahita Torkaman‐Boutorabi, G. Shahidi S. Choopani, Mohammad Ebrahim Rezvani, Kosar Pourkosary, Majid Golkar, Mohammad‐Reza Zarrindast, Mohammad-Reza Zarrindast   +6 more
openalex   +2 more sources

Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background As Parkinson's disease (PD) progresses, motor fluctuations become increasingly difficult to manage with oral medications. Foslevodopa/foscarbidopa (LDp/CDp), delivered as a continuous 24‐h/day subcutaneous infusion, offers continuous levodopa delivery and stable plasma levodopa levels that reduce motor fluctuations. LDp/CDp has been
K. Ray Chaudhuri, Bruno Bergmans, Eric Freire‐Alvarez, Lucie Hopes, Drew S. Kern, Robert S. Kirsner, Giulia Lazzeri, Pedro Mendes‐Bastos, Noriko Nishikawa, Per Odin, Karolina Poplawska‐Domaszewicz, Rajesh Pahwa, Yuval Ramot, Klaus Seppi, Tobias Warnecke, Robert Wiggins, Megha B. Shah, Pavnit Kukreja, Bjoern Fritz, Koray Onuk, Stuart H. Isaacson   +20 more
wiley   +1 more source

Spectrophotometric Determination of Catecholamines Via Charge Transfer Complexation with Bromanil, Applications to Catecholamine Drug Formulations

Science Journal of University of Zakho, 2013
A simple, sensitive, rapid and low-cost spectrophotometric method for catecholamine (levodopa, methyldopa and dopamine) determination in pure and drug formulations is described.
MAHMOOD A. HASAN
doaj  

Levodopa Does Not Worsen Gastric Emptying in Parkinson's Disease [PDF]

, 2015
Shunsuke Shiina, Ryuji Sakakibara, Hirokazu Doi, Fuyuki Tateno, Mitsutoshi Sato, Tohru Masaka, Masahiko Kishi, Yohei Tsuyusaki, Tsuyoshi Ogata, Yosuke Aiba, Hiromi Tateno   +10 more
openalex   +1 more source

Another Microlesion Effect after STN‐DBS for Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Atsushi Umemura, Genko Oyama, Kenya Nishioka, Nobutaka Hattori   +3 more
wiley   +1 more source

Effects of fibroblast transplantation into the internal pallidum on levodopa-induced dyskinesias in parkinsonian non-human primates

, 2015
Arun Singh, C.A. Gutekunst, Subramaniam Uthayathas, J. P. M. Finberg, Klaus Mewes, Robert E. Gross, Stella M. Papa, Yair Feld   +7 more
openalex   +1 more source